CLASS II ONGOING Device recall · Reported 12 Jan 2022 · FDA Enforcement Report

Alinity m System recalled by Abbott Molecular

Abbott Molecular is recalling Alinity m System, distributed nationwide in the US. The recall was initiated on 6 Dec 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAlinity m System, Model 08N53-002, all serial numbers
Quantity recalled742 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0461-2022
FDA event ID
89167
Recalling firm
Abbott Molecular, Des Plaines, IL
Classification
Class II
Status
Ongoing
Recall initiated
6 Dec 2021
FDA classified
6 Jan 2022
Reported
12 Jan 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

6 Dec 2021Recall initiated by company
6 Jan 2022Classified by FDA+31 days
12 Jan 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a software issue associated with the ability to properly complete a Field Service Engineer Maintenance and Diagnostics procedure.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Alinity m System, Part No. 08N53-002

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Cambodia, Canada, Chile, Colombia, Czech Republic, Egypt, El Salvador, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Malawi, Malaysia, Mexico, Montenegro, Morocco, Mozambique, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Uganda, United Kingdom, and Vietnam.

Nationwide

Questions about this recall

Why was it recalled?

There is a software issue associated with the ability to properly complete a Field Service Engineer Maintenance and Diagnostics procedure.

Which lots are affected?

Alinity m System, Model 08N53-002, all serial numbers

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Cambodia, Canada, Chile, Colombia, Czech Republic, Egypt, El Salvador, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Malawi, Malaysia, Mexico, Montenegro, Morocco, Mozambique, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Uganda, United Kingdom, and Vietnam.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Abbott Molecular

All 36

Other Other Medical Devices recalls

All 13,908